Agilent Technologies (A)
(Delayed Data from NYSE)
$137.32 USD
+2.34 (1.73%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $137.32 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$137.32 USD
+2.34 (1.73%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $137.32 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
DXC Technology (DXC) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Weakness in the traditional business and a tepid IT spending environment are likely to have negatively impacted DXC Technology's (DXC) Q4 performance.
monday.com (MNDY) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
monday.com's (MNDY) first-quarter 2024 results are expected to reflect continued strength in the CRM and Enterprise segments.
StoneCo (STNE) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
StoneCo's (STNE) first-quarter 2024 performance will likely reflect strength in its financial services and software business.
Sea Limited (SE) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Sea Limited's (SE) first-quarter 2024 performance will likely benefit from the diversification of overall service offerings despite macroeconomic challenges.
What's in Store for QuickLogic (QUIK) This Earnings Season?
by Zacks Equity Research
QuickLogic's (QUIK) first-quarter 2024 performance is likely to have gained from the growing adoption of its sensor processing solutions and embedded FPGA Intellectual Property Licensing platform.
DigitalOcean (DOCN) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
DigitalOcean's (DOCN) first-quarter 2024 performance is likely to reflect benefits from a robust product portfolio and strong demand for its cloud services.
What's in the Offing for Gen Digital (GEN) This Earnings Season?
by Zacks Equity Research
While the increased demand for cybersecurity and ID analytics solutions is expected to aid Gen Digital's (GEN) Q4 top line, higher interest expenses and the equity dilution impact are likely to have weighed on the bottom line.
Immersion (IMMR) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Immersion's (IMMR) first-quarter performance is likely to have gained from the new business wins and renewal of contracts in gaming, automotive and AR/VR space.
DHI Group (DHX) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
DHI Group's (DHX) first-quarter 2024 performance is likely to have benefited from its diversified portfolio and improvement in bookings environment across all new business divisions.
Perion Network (PERI) to Report Q1 Earnings: What to Expect
by Zacks Equity Research
Perion Network's (PERI) first-quarter earnings are expected to have benefited from its diversified portfolio in the advertising industry.
These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Agilent Technologies (A) is a Top Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Cognex Corporation (CGNX) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Cognex (CGNX) delivered earnings and revenue surprises of 37.50% and 6.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Want Better Returns? Don?t Ignore These 2 Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Waters (WAT) Boosts Waters Operating Segment With HPLC System
by Zacks Equity Research
Waters (WAT) launches Alliance iS Bio HPLC system to improve efficiency across biopharma QC laboratories, boosting its Waters Operating segment.
Agilent (A) is Set for Analytica 2024 With Advanced Products
by Zacks Equity Research
Agilent (A) plans to showcase its new products for analytical laboratories at Analytica 2024, boosting its overall product portfolio.
Agilent (A) to Bolster DCG Segment With Upcoming Solutions
by Zacks Equity Research
Agilent (A) plans to introduce new solutions for cancer research and diagnosis, boosting its DCG segment.
Agilent (A) Boosts LSAG Segment With Advanced Dilution System
by Zacks Equity Research
Agilent (A) unveils ADS 2 to enhance workflow efficiency within the laboratory, boosting the LSAG segment.
Earnings Growth & Price Strength Make Agilent Technologies (A) a Stock to Watch
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
Agilent (A) Up 7.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
New to Investing? This 1 Computer and Technology Stock Could Be the Perfect Starting Point
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Why Agilent Technologies (A) is a Top Stock for the Long-Term
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Should You Invest in the First Trust Water ETF (FIW)?
by Zacks Equity Research
Sector ETF report for FIW